title: Neurologic soft signs in obsessive-compulsive disorder.
authors.forename: K
authors.initials: K
authors.lastname: Bihari
authors.forename: M T
authors.initials: MT
authors.lastname: Pato
authors.forename: J L
authors.initials: JL
authors.lastname: Hill
authors.forename: D L
authors.initials: DL
authors.lastname: Murphy
mesh_terms: D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000150:complications / Q000175:diagnosis*; D002997:Clomipramine / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use
chemical_list: D010879:Piperazines; D005473:Fluoxetine; D003000:Clonidine; D002997:Clomipramine; C015068:1-(3-chlorophenyl)piperazine